Pfizer Inc
Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), the antibiotic Zithromax (azithromycin), Viagra (sildenafil) for erectile dysfunction, and the anti-inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside the USA and Canada, mainly in South America). Its headquarters are in Midtown Manhattan, New York City.
Source: Wikipedia
Campaign Finance
$42,039,599 GivenFigures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.
-
Top Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
-
Republicans vs. Democrats
in dollars. "Other" includes 3rd parties and organizations without official party affiliation. -
State vs. Federal
in dollars -
Top PAC Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
Lobbying
$131,106,536 SpentFigures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Pfizer Inc
-
Names of Lobbyists
-
Firm Hired Amount Pfizer Inc $122,910,000 Wyeth $2,459,268 Warner-Lambert $2,240,000 -
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Medicare & Medicaid,
- Trade,
- Taxes,
- Copyright, Patent & Trademark,
- Pharmacy,
- Fed Budget & Appropriations,
- Consumer Product Safety,
- Agriculture,
- Torts
-
Most Frequently Disclosed Bills
Bill No. Title H.R.1548 Pathway for Biosimilars Act H.R.1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R.4213 Tax Extenders Act of 2009 H.R.965 Preservation of Antibiotics for Medical Treatment Act of 2011 H.R.3200 America's Affordable Health Choices Act of 2009 S.301 Physician Payments Sunshine Act of 2009 H.R.3590 Service Members Home Ownership Tax Act of 2009 H.R.1 American Recovery and Reinvestment Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009
Regulations
Mentioned in 1571 dockets; Submitted to 163 docketsAll data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Pfizer Inc" in public comments on proposed federal regulations.
-
Documents Submitted by the Organization
View all submissions data for Pfizer Inc
Sources:
Regulations.gov
-
Mentions in Document Text
View all mentions data for Pfizer Inc
Sources:
Regulations.gov
Federal Spending
25 contractsFederal grants, contracts and loans are reported by federal agencies using the FPDS and FAADS systems. The data is made available to the public at USASpending.gov. Please note that the completeness and quality of the data varies greatly by agency.
Only grants, contracts and loans with amounts over $1 million are shown.
Because company names are not reported in a standardized manner, we cannot reliably determine the company receiving the contract or award. The results shown here are based on a search for the company name. Individual records may be missed or erroneously included because of name variations. For more information, please see our federal spending methodology page.
Note: Company names in federal spending data are not standardized. The table below is included only as a sample of what is available in the data and has not been reviewed for accuracy or completeness. To investigate the data further, use the links at the bottom of the table.
| Type | Recipient Name | Year | Agency | Description | Amount |
|---|---|---|---|---|---|
contract |
Pfizer Inc. | 2012 | Centers For Disease Control | PFIZER VFC 2011 | $287,552,818 |
contract |
Pfizer Inc. | 2011 | Centers For Disease Control | VACCINE FOR CHILDREN 2011 | $281,640,506 |
contract |
Pfizer Inc. | 2012 | Centers For Disease Control | VFC 2012 | $272,238,691 |
contract |
Pfizer Inc. | 2012 | Centers For Disease Control | VFC 2012 | $230,002,760 |
contract |
Pfizer Inc. | 2012 | Centers For Disease Control | VFC 2012 | $140,041,787 |
contract |
Pfizer Inc. | 2012 | Centers For Disease Control | PFIZER VFC 2011 | $131,240,596 |
contract |
Pfizer Inc. | 2011 | Centers For Disease Control | PFIZER VFC 2011 | $111,038,414 |
contract |
Pfizer Inc. | 2011 | Centers For Disease Control | VACCINE FOR CHILDREN 2011 | $103,135,727 |
contract |
Pfizer Inc. | 2012 | Centers For Disease Control | VFC 2012 | $96,027,716 |
contract |
Pfizer Inc. | 2011 | Centers For Disease Control | PFIZER VFC 2011 | $92,835,550 |
Contractor Misconduct
11 InstancesThis information is collected by the Project On Government Oversight from press releases, court documents, news reports and other public records. It is not meant to be an exhaustive account of all instances of federal contractor misconduct.
More information on each instance, including primary source documents, is available on POGO's site by clicking on the instance description. More information on POGO's methodology is available here.
| Misconduct Type | Hired By | Incident | Year | Disposition | Penalty |
|---|---|---|---|---|---|
| Health | None | Illegal Marketing of Bextra and Other Drugs | 2009 | Pleaded Guilty | $2,300,000,000 |
| Government Contract Fraud | Health and Human Servs. | Sandler et al. v. Wyeth Pharmaceuticals | 2005 | Settlement | $491,000,000 |
| Health | None | Illegal Marketing of Neurontin | 2004 | Pleaded Guilty | $430,000,000 |
| Health | None | Illegal Testing in Nigeria | 2009 | Settlement | $75,000,000 |
| Government Contract Fraud | Multiple Agencies | Lipitor False Claims | 2002 | Settlement | $49,000,000 |
| Health | None | Illegal Marketing of Genotropin | 2007 | Pleaded Guilty | $34,700,000 |
| Health | None | U.S. ex rel. Wetherholt and Drimer v. Pfizer (Illegal Marketing of Detrol) | 2011 | Settlement | $14,500,000 |
| Antitrust | None | Hawaii Average Wholesale Price Litigation | 2010 | Settlement | $8,200,000 |
| Labor | None | McClain v. Pfizer (Whistleblower Retaliation) | 2007 | Judgment Against Defendant | $1,370,000 |
| Health | None | Lipitor Webpage Misbranding | 2011 | Investigative Finding | $0 |
| Health | None | FDA Inspection of New York City Facility | 2010 | Investigative Finding | $0 |
EPA Violations
20 Enforcement ActionsFigures are based on data from the Environmental Protection Agency’s ECHO website. The ECHO database contains federal and state environmental enforcement actions. Data displayed here includes only those actions that began after 2000 and resulted in fines of over $1 million.
Actions where the company was the sole defendant are listed first. Actions where the company is one of multiple defendants are listed subsequently.
For more information see our EPA methodology page.
| Case Name | Defendant | Date | Locations | Amount |
|---|---|---|---|---|
| Pharmacia Corporation (Industri-Plex Site) | Pharmacia Corporation (+1 others) | 2008 | Woburn, Ma | $37,245,000 |
| Alliance Chemical Inc Et Al. | Pharmacia Corp fka Monsanto Company (+71 others) | 2007 | Newark, Nj | $37,000,000 |
| Sauget Area 2 Unilateral Admin Order (Cercla) | Pharmacia Corp (+76 others) | 2002 | Sauget, Il | $26,500,000 |
| Pharmacia Corporation/ Industri-Plex Site Ou-2 | Pharmacia Corporation (+1 others) | 2007 | Woburn, Ma | $25,600,000 |
| Air Products & Chemical, Inc Et Al | Pharmacia Corporation (+40 others) | 2005 | Elkton, Md | $24,500,000 |
| 3m Company | Warner-Lambert Company LLC (+106 others) | 2008 | Wood Ridge, Nj | $18,000,000 |
| Alcan Corporation | Pharmacia Corporation f/k/a Monsanto Company (+81 others) | 2007 | Newark, Nj | $13,150,000 |
| Casmalia - De Minimis Aoc | Pfizer Inc. (+191 others) | 2004 | Casmalia, Ca | $11,900,000 |
| Agere Systems, Et Al | Pharmacia Corporation/Monsanto (+138 others) | 2007 | Elkton, Md | $11,300,000 |
| Anniston Pcb Site | Pharmacia Corporation (+2 others) | 2003 | Anniston, Al | $11,218,346 |
Advisory Committees
58 people on 48 committeesData is based on disclosures required by the Federal Advisory Committee Act (FACA). Matches are based on the occurrence of the company name in the committee member affiliation. Variations in company names may cause some matches to be missed.
The table shows only the top 10 agencies. To search and download raw records from the complete dataset see the FACA data section.
Table shows employees of "Pfizer Inc" that sat on federal advisory committees.
View all advisory committee data for Pfizer Inc